Third Rock Ventures

Rapport Therapeutics raised $150M on August 23, 2023

Investors: Logos Global Management, LP, Surveyor Capital, Goldman Sachs Asset Management, Sofinnova Ventures, Russia technology fund, T. Rowe Price, Perceptive Advisors and Third Rock Ventures

Septerna raised $150M on July 11, 2023

Investors: Goldman Sachs Asset Management, The Invus Group, Woodline Partners LP, RA Capital Management, L.P., Soleus Capital Management, L.P., Samsara BioCapital, Logos Global Management, LP, Vertex Ventures HC and Third Rock Ventures

Flare Therapeutics raised $123M on March 22, 2023

Investors: ShangBay Capital, Eventide Asset Management, Nextech Invest, The Invus Group, GordonMD Global Investments LP and Third Rock Ventures

Rapport Therapeutics raised $100M on March 7, 2023

Investors: ARCH Venture Partners and Third Rock Ventures

CARGO Therapeutics raised $200M on March 1, 2023

Investors: Nextech Invest, Perceptive Advisors, Red Tree Venture Capital, RTW Investments, LP, T. Rowe Price, Samsara BioCapital, Wellington Management and Third Rock Ventures

Casma Therapeutics raised $46M on November 15, 2022

Investors: Eventide Management Partners, Schroders Capital, Astellas Venture Capital L.L.C., The Column Group, Eisai Asia, Mirae Asset MAPS Global Investments Co., Ltd and Third Rock Ventures

Terremoto Biosciences raised $75M on May 25, 2022

Investors: OrbiMed Advisors and Third Rock Ventures

Undisclosed raised $150M on May 10, 2022

Investors: Nextech Invest, The Invus Group, Section 32, LifeSci Venture Partners, Goldman Sachs Asset Management and Third Rock Ventures

Celsius Therapeutics raised $83M on March 24, 2022

Investors: Heritage Physician Networks, 苏州凯风正德投资管理有限公司, Catalio Capital Management, Section 32, GV, Casdin Capital, LLC, Amplitude Ventures, Fast Track Initiative and Third Rock Ventures

Septerna raised $100M on January 27, 2022

Investors: Catalio Capital Management, Samsara BioCapital, Logos Global Management, LP, Casdin Capital, LLC, The Invus Group and Third Rock Ventures